We have located links that may give you full text access.
An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience.
Journal of Clinical Research in Pediatric Endocrinology 2023 April 19
INTRODUCTION: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems with this syndrome may include cardiac abnormalities, immune dysfunction, facial dysmorphism, endocrine, genitourinary and gastrointestinal problems, and developmental delay. This study aims to evaluate and present all endocrinological findings of patients with 22q11.2 DS.
MATERIALS AND METHODS: The seventeen participants in this study were all FISH confirmed 22q11.2 DS cases with hypoparathyroidism who had been followed in our Pediatric Endocrinology clinic.
RESULTS: In the physical examination, it was observed that all patients had similar facial findings. The median age at diagnosis was 45 days (1 day-13 year). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dl, phosphorus was 6.2±1.1 mg/dl, and median PTH was 11.5 ng/L (3.7-47.6). Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between permanent and transient hypoparathyroidism cases regarding gender, age at diagnosis, calcium, phosphorus, and PTH. But vitamin D deficiency was noted in the transient cases. During follow-up short stature, obesity, and type 2 diabetes mellitus were not detected. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Pathological short stature was not seen in patients, but their final stature was shorter than the general population (mean height SDS: -0.94±0.83).
CONCLUSIONS: Hypocalcemia may detect during acute illness in some cases where hypocalcemia appears in advanced age. There was no significant difference between permanent and transient hypoparathyroidism cases in PTH levels. Recognition of the more specific facial findings mentioned in the study is important regarding genetic diagnosis, additional anomaly, and follow-up.
MATERIALS AND METHODS: The seventeen participants in this study were all FISH confirmed 22q11.2 DS cases with hypoparathyroidism who had been followed in our Pediatric Endocrinology clinic.
RESULTS: In the physical examination, it was observed that all patients had similar facial findings. The median age at diagnosis was 45 days (1 day-13 year). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dl, phosphorus was 6.2±1.1 mg/dl, and median PTH was 11.5 ng/L (3.7-47.6). Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between permanent and transient hypoparathyroidism cases regarding gender, age at diagnosis, calcium, phosphorus, and PTH. But vitamin D deficiency was noted in the transient cases. During follow-up short stature, obesity, and type 2 diabetes mellitus were not detected. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Pathological short stature was not seen in patients, but their final stature was shorter than the general population (mean height SDS: -0.94±0.83).
CONCLUSIONS: Hypocalcemia may detect during acute illness in some cases where hypocalcemia appears in advanced age. There was no significant difference between permanent and transient hypoparathyroidism cases in PTH levels. Recognition of the more specific facial findings mentioned in the study is important regarding genetic diagnosis, additional anomaly, and follow-up.
Full text links
Related Resources
Trending Papers
Prevention and management of venous thrombosis in patients with cirrhosis.British Journal of Haematology 2024 August 26
Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management.American Journal of Hematology 2024 September 6
Arrhythmogenic Mitral Valve Prolapse: Can We Risk Stratify and Prevent Sudden Cardiac Death?Arrhythmia & Electrophysiology Review 2024
Clinical Evaluation and Management of Thrombotic Microangiopathy.Arthritis & Rheumatology 2024 Februrary
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app